-
Je něco špatně v tomto záznamu ?
Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors
T. Moysiadis, P. Baliakas, D. Rossi, M. Catherwood, JC. Strefford, J. Delgado, A. Anagnostopoulos, C. Belessi, N. Stavroyianni, S. Pospisilova, D. Oscier, G. Gaidano, E. Campo, R. Rosenquist, P. Ghia, K. Stamatopoulos,
Jazyk angličtina Země Velká Británie
Typ dokumentu srovnávací studie, dopisy, práce podpořená grantem
NLK
ProQuest Central
od 2000-01-01 do Před 1 rokem
Open Access Digital Library
od 1997-01-01
Nursing & Allied Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
- MeSH
- časové faktory MeSH
- chronická lymfatická leukemie diagnóza genetika MeSH
- klonální evoluce * MeSH
- lidé MeSH
- mutace * MeSH
- nádorové biomarkery genetika MeSH
- prognóza MeSH
- receptory antigenů B-buněk genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
Department of Haematology Royal Bournemouth Hospital Bournemouth UK
Department of Hemato Oncology Belfast City Hospital Belfast UK
Division of Hematology Oncology Institute of Southern Switzerland Bellinzona Switzerland
Hematology Department and HCT Unit G Papanicolaou Hospital Thessaloniki Greece
Hematology Department Hospital Clinic Barcelona Spain
Hematology Department Nikea General Hospital Pireaus Greece
Institute of Applied Biosciences Center for Research and Technology Hellas Thessaloniki Greece
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045030
- 003
- CZ-PrNML
- 005
- 20200113081620.0
- 007
- ta
- 008
- 200109s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41375-018-0322-7 $2 doi
- 035 __
- $a (PubMed)30679797
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Moysiadis, Theodoros $u Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
- 245 10
- $a Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors / $c T. Moysiadis, P. Baliakas, D. Rossi, M. Catherwood, JC. Strefford, J. Delgado, A. Anagnostopoulos, C. Belessi, N. Stavroyianni, S. Pospisilova, D. Oscier, G. Gaidano, E. Campo, R. Rosenquist, P. Ghia, K. Stamatopoulos,
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 12
- $a klonální evoluce $7 D060965
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chronická lymfatická leukemie $x diagnóza $x genetika $7 D015451
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a receptory antigenů B-buněk $x genetika $7 D011947
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Baliakas, Panagiotis $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
- 700 1_
- $a Rossi, Davide $u Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
- 700 1_
- $a Catherwood, Mark $u Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK.
- 700 1_
- $a Strefford, Jonathan C $u Cancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, Southampton, UK.
- 700 1_
- $a Delgado, Julio $u Hematology Department, Hospital Clinic, Barcelona, Spain.
- 700 1_
- $a Anagnostopoulos, Achilles $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
- 700 1_
- $a Belessi, Chrysoula $u Hematology Department, Nikea General Hospital, Pireaus, Greece.
- 700 1_
- $a Stavroyianni, Niki $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
- 700 1_
- $a Pospisilova, Sarka $u Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Oscier, David $u Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
- 700 1_
- $a Gaidano, Gianluca $u Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
- 700 1_
- $a Campo, Elias $u Hematopathology Section, Laboratory of Pathology, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
- 700 1_
- $a Rosenquist, Richard $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Ghia, Paolo $u Division of experimental Oncology, IRCCS Istituto Scientfico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
- 700 1_
- $a Stamatopoulos, Kostas $u Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece. kostas.stamatopoulos@gmail.com. Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. kostas.stamatopoulos@gmail.com.
- 773 0_
- $w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 33, č. 7 (2019), s. 1801-1805
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30679797 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113081952 $b ABA008
- 999 __
- $a ok $b bmc $g 1483299 $s 1083703
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 33 $c 7 $d 1801-1805 $e 20190124 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
- LZP __
- $a Pubmed-20200109